Mylan eyes pediatric products for future Indian growth
This article was originally published in Scrip
Executive Summary
More details of Mylan's scale-up plans in India are now emerging, with the US firm confirming to Scrip that it expects to introduce a hematinic product in the country and is also eyeing a potential entry into the pediatric health space going forward.